middle.news
How Pathkey.AI’s TrialKey AI Boosted Biotech Stocks by 43.6% in September
9:26am on Thursday 9th of October, 2025 AEDT
•
Healthcare
Read Story
How Pathkey.AI’s TrialKey AI Boosted Biotech Stocks by 43.6% in September
9:26am on Thursday 9th of October, 2025 AEDT
Key Points
Four new clinical trial outcomes confirmed TrialKey’s predictive accuracy in September 2025
Average share price gain of 43.6% observed from TrialKey prediction to trial result announcement
Eleven ongoing trials monitored with an average 16.7% return on yet-to-report stocks
TrialKey insights applied in trial optimisation, insurance, and biotech investing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pathkey.Ai (ASX:PKY)
OPEN ARTICLE